COVID-19 pandemic-the learning continues

Anaesthesia, Pain & Intensive Care

ARTICLE

Pranav Bansal¹  Kirti Ahuja¹  Saru Singh¹  Shivani Sharma² 

[1] Department of Anaesthesiology & Critical Care, BPS Govt Medical College;Dept. of Physiology, Medical University of the Americas, St. Kitts & Nevis.

关键词: Covid-19;    Corona virus;    Tocilizumab;    Hydroxychloroquine;    Plasma therapy;   

DOI  :  10.35975/apic.v24i3.1301

学科分类：社会科学、人文和艺术（综合）

来源: THK

【 摘 要 】

The Covid-19 pandemic is the most severe global health crisis of our time and greatest challenge to mankind after World War II. A combination of therapies including vitamins, hydroxychloroquine, steroids, plasma therapy and immunomodulators have proved to be effective in symptomatic cases but no specific drug or vaccine has been developed to fight covid-19 till date. Till the time new vaccine rolls out, trials are evaluating the efficacy of BCG in fighting against Covid-19. The Covid-19 with its high propensity of transmission, especially through asymptomatic carriers has been spreading rapidly since the outbreak of the disease. With the existing lacunas in ongoing preventive and management strategies and increasing risk of community transmission, the role of development of herd immunity in control of covid-19 can play a major role.

【 授权许可】

CC BY-NC